Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 564 | 19,371 | 21,170 | 36,392 | 40,031 |
| Marketable Securities | N/A | 2,496 | 20,971 | 4,925 | 25,232 |
| Other current assets | 122 | 0 | 0 | 0 | 0 |
| TOTAL | $764 | $23,236 | $43,480 | $42,755 | $66,608 |
| Non-Current Assets | |||||
| PPE Net | 459 | 263 | 259 | 372 | 224 |
| Other Non-Current Assets | 0 | 22 | 240 | 393 | 706 |
| TOTAL | $459 | $285 | $499 | $765 | $930 |
| Total Assets | $1,223 | $23,521 | $43,979 | $43,520 | $67,538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 716 | 441 | 291 | 556 | 1,020 |
| Accrued Expenses | 2,635 | 2,637 | 8,949 | 4,523 | 2,576 |
| Other current liabilities | N/A | N/A | N/A | N/A | 537 |
| TOTAL | $3,351 | $3,078 | $9,240 | $5,079 | $4,133 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,351 | $3,078 | $9,240 | $5,079 | $4,133 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,843 | 481 | 442 | 415 | 413 |
| Common Shares | 3 | N/A | 18 | 17 | 16 |
| Retained earnings | -12,782 | -210,470 | -189,741 | -159,777 | -131,251 |
| Other shareholders' equity | 0 | 21,528 | 21,509 | 0 | -11 |
| TOTAL | $-2,128 | $20,443 | $34,739 | $38,441 | $63,405 |
| Total Liabilities And Equity | $1,223 | $23,521 | $43,979 | $43,520 | $67,538 |